A research project by Ida Catharina Püschl
Preeclampsia is a major cause of maternal and fetal morbidity and mortality, which may manifest rapidly at any time after week 20 of gestation. Despite research efforts, there is currently no effective screening test to identify which pregnant women will develop preeclampsia. In a pilot study of 137 maternities reported by the University of Southampton (2015, Bas van Rijn et al.), monitoring the weekly salivary uric acid levels in pregnant women indicated potential to enhance predictive capability for pre-eclampsia and related outcomes. Based on this, Morgan Innovation and Technology has invented a hometest suitable for self-monitoring of salivary uric acid levels –the ”Salurate”-test-device. The test is operated by a telemedical solution using a smartphone app.
In a prospective cohort study of 563 pregnant women: investigate the predictive potential of salivary uric acid in relation to the development of pre-eclampsia and secondary outcomes.
20 women participating in qualitative interviews
Exploring pregnant womens attitude towards self-monitoring using a telemedic solution.
30 women during labor
Investigating the origin of raised salivary uric comparing levels in saliva, blood, amniotic fluid and cord blood in maternal vs fetal distress.